Chargement en cours...
MicroRNA Biomarkers for Coronary Artery Disease?
MicroRNA (miRNA, miR) measurements in patients with coronary heart disease are hampered by the confounding effects of medication commonly used in cardiovascular patients such as statins, antiplatelet drugs, and heparin administration. Statins reduce the circulating levels of liver-derived miR-122. A...
Enregistré dans:
| Publié dans: | Curr Atheroscler Rep |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer US
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613887/ https://ncbi.nlm.nih.gov/pubmed/26490079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11883-015-0548-z |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|